Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Author's Avatar
Jun 01, 2022

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences: